课题基金 / 基金详情

TERMINATION OF PTH RESPONSES IN OSTEOBLASTS

TERMINATION OF PTH RESPONSES IN OSTEOBLASTS
成骨细胞中 PTH 反应的终止
批准号:
7104895
负责人:
EDWARD M. GREENFIELD
金额:
$27.64万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2007-07-31

项目摘要

项目成果

EDWARD M. GREENFIELD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): PTH and PTHrP are important regulators of calcium homeostasis and bone turnover in many diseases. Many of the effects of PTH, PTHrP, and other GPCR agonists on gene expression are transient. We have recently shown that the primary mechanism(s) responsible for termination of gene regulation following stimulation by PTH or ¿-adrenergic agonists is(are) downstream of receptor desensitization, adenyl cyclase activation, and cAMP degradation. PTH and ¿-adrenergic agonists also stimulate PKA activity and transcription factor phosphorylation in a transient fashion. Thus, it is likely that termination of PKA activity is responsible for termination of downstream events, including transcription factor phosphorylation and gene regulation. When overexpressed, protein kinase inhibitor (PKI) inactivates PKA. We therefore hypothesize that termination of PKA activity by PKI is primarily responsible for termination of gene regulation following stimulation by PTH or ¿-adrenergic agonists. Despite the large number of studies examining purified or overexpressed PKI, little is known about the physiological role of these molecules in cells. Our proposed experiments will be the first to determine whether endogenous levels of PKI are sufficient to reduce PKA activity or downstream gene regulation. Our specific aims are: 1) Test the hypothesis that endogenous PKI interacts with PKA following stimulation by PTH or isoproterenol; 2) Test the hypothesis that endogenous PKI is primarily responsible for termination of both PKA activity and gene regulation following stimulation by PTH or isoproterenol; 3) Test the hypothesis that termination of PTH-induced gene regulation by endogenous PKI is physiologically important. These experiments will substantially increase our understanding of the role of PKI in both PKA signaling and gene regulation in mesenchymal cells as well as the mechanisms responsible for balancing the catabolic effects of PTH. Our findings will also serve as paradigm for regulation of PKA signaling in other cell types.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.2174/1874-470211205020127
发表时间: 2012-05
期刊: Current molecular pharmacology
影响因子: 2.7
作者: [E. Greenfield]
通讯作者: E. Greenfield
Regulation of age-related bone loss by PKIgamma
Regulation of age-related bone loss by PKIgamma
Regulation of age-related bone loss by PKIgamma
P2X7R: a novel therapeutic target in implant loosening
  • 批准号:
    9244951
  • 项目类别:
  • 资助金额:
    $16.72万
  • 财政年份:
    2017
  • 负责人:
    EDWARD M. GREENFIELD
  • 依托单位:
海外基金